Addex Therapeutics Ltd Cash Flow Reinvestment Rate

Latest as of December 2020: 0.07x

Addex Therapeutics Ltd cash flow reinvestment rate. Addex Therapeutics Ltd (ADXN) has a Cash Flow Reinvestment Rate of 0.07x as of December 2020, reinvesting CHF49.23K (capex CHF48.09K plus investments CHF1.15K) from operating cash flow of CHF704.85K. Explore Addex Therapeutics Ltd (ADXN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.07x

(Capex + Investments) / Operating CF

Total Reinvested

CHF49.23K

Capex + Investments

Operating Cash Flow

CHF704.85K

CHF

Capital Expenditures

CHF48.09K

CHF

Cash Flow Reinvestment Rate of Addex Therapeutics Ltd (2018–2018)

Cash flow reinvestment rate of Addex Therapeutics Ltd from 2018 to 2018. Historical reinvestment intensity for Addex Therapeutics Ltd across 1 annual periods. Explore ADXN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Addex Therapeutics Ltd Cash Flow Reinvestment Rate by Year (2018–2018)

Addex Therapeutics Ltd cash flow reinvestment rate by year from 2018 to 2018. Year-by-year capital reinvestment analysis for Addex Therapeutics Ltd. For the full cash flow conversion analysis, see how efficiently does Addex Therapeutics Ltd generate cash.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2018	0.03x	CHF56.37K	CHF1.75 Million	CHF9.05K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow